[go: up one dir, main page]

HK40112689A - Formulations of radiprodil - Google Patents

Formulations of radiprodil Download PDF

Info

Publication number
HK40112689A
HK40112689A HK62024100779.3A HK62024100779A HK40112689A HK 40112689 A HK40112689 A HK 40112689A HK 62024100779 A HK62024100779 A HK 62024100779A HK 40112689 A HK40112689 A HK 40112689A
Authority
HK
Hong Kong
Prior art keywords
radiprodil
formulations
Prior art date
Application number
HK62024100779.3A
Other languages
Chinese (zh)
Inventor
Marie Genin
Pierandrea Muglia
Original Assignee
Grin Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grin Therapeutics, Inc. filed Critical Grin Therapeutics, Inc.
Publication of HK40112689A publication Critical patent/HK40112689A/en

Links

HK62024100779.3A 2021-08-06 2022-08-05 Formulations of radiprodil HK40112689A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163230331P 2021-08-06

Publications (1)

Publication Number Publication Date
HK40112689A true HK40112689A (en) 2025-01-24

Family

ID=

Similar Documents

Publication Publication Date Title
EP4271402A4 (en) Composition of bl-8040
EP4251153A4 (en) Lyophilized formulations of tegavivint
EP4099999A4 (en) Formulations of docetaxel
EP4057941A4 (en) Stable formulations of silk-derived protein
HK40112689A (en) Formulations of radiprodil
HK40117787A (en) Stable formulations of shr0302
HK40115571A (en) Formulations of docetaxel
HK40116379A (en) Formulations of docetaxel
HK40115248A (en) Formulations of docetaxel
HK40115247A (en) Formulations of docetaxel
HK40116380A (en) Formulations of docetaxel
HK40101567A (en) Oral formulations of tenapanor
HK40106938A (en) Formulations of l-asparaginase
HK40109619A (en) Formulations
HK40109650A (en) Formulations
HK40087872A (en) Formulations of cabazitaxel
HK40122546A (en) Combination formulation of cedazuridine
HK40117580A (en) Combination formulation of cedazuridine
HK40099027A (en) Formulations
HK40102138A (en) Formulations of psilocybin
HK40109219A (en) Formulations of apremilast
HK40087548A (en) Formulations
HK40090532A (en) Formulations of anti-il-33 antibodies
AU2023903711A0 (en) Formulations
AU2020903873A0 (en) Lymph-Targeting Formulations